|View printer-friendly version|
ESI, established in 2000 in
BRICOH has established clinical cell manufacturing facilities to produce clinical grade banks of cGMP grade hES stem cells for its affiliates and collaborators, including academic and other medical research institutions or companies engaged in research and development into cell replacement therapies for the treatment of diseases addressed by the emerging field of regenerative medicine.
Users of BioTime’s hES cells, including those who acquire ESI hES cells through BRICOH, may need to obtain a license or other permission from
BioTime’s subsidiaries include: publicly-traded
Statements pertaining to future financial and/or operating results, future growth in research, technology, clinical development, and potential opportunities for
To receive ongoing
Judith Segall, 510-521-3390, ext 301
EVC Group, Inc.
Gregory Gin, 862-236-0673
Michael Polyviou, 212-850-6020
Doug Sherk, 415-652-9100
Gotham Communications, LLC
Bill Douglass, 646-504-0890